Stolen laptop affects 513 Georgia patients

Jeff Byers | | Health Exec | Policy & Regulations
laptop secuirty - 36.02 Kb
Georgia Health Sciences University (GHSU) has notified 513 patients about the theft of a laptop computer that may have contained some of their personal information.

On Jan. 18, a nurse practitioner who works in sickle cell clinics across Georgia, including the Georgia Health Sciences Adult Sickle Cell Clinic, had a laptop computer stolen from her home, according to the Augusta-based GHSU. The information in the records on the laptop was limited to name, date of birth, limited diagnosis information and an internal code associated with the patient’s laboratory tests. The records did not include addresses, social security numbers or financial information.

“We have taken steps to further strengthen our security efforts and are making every attempt to personally notify patients whose information may have been involved,” said Christine Adams, enterprise privacy officer, in a statement.


Jeff Byers

Related Content

Report: UnitedHealth under investigation by DOJ for Medicare Advantage upcoding
FDA approves first therapy for very rare lipid storage disorder
FDA announces Class I recall of Boston Scientific pacemakers—replacement may be necessary
FDA ends semaglutide shortage, closing the door on compounded Wegovy, Ozempic
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues
Federal judge sides with FTC; case against PBMs to move forward

Around the web

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiovascular Business
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”